Tuesday, May 24, 2022

TOPICS

Home Tags Amgen

Tag: Amgen

Making Sustainability Work: The Road to Net Zero

Sustainability is often defined as conducting business in an ethical manner that yields long-term, sustainable benefits, meeting the needs of the present without compromising...
CLOSE EYE: From left, associate manufacturer Adeline Lamothe, manufacturing process technician contract worker Austin White and associate manufacturer David Folco check the single-use bioreactors, which are used to control the conditions for generating protein cells at Amgen Rhode Island in West Greenwich. / COURTESY AMGEN INC.

Team approach allows Amgen to complete new biomanufacturing plant in 2020

PBN Manufacturing Awards 2021 Overall Excellence at an Enterprise Manufacturer: Amgen Rhode Island Amgen Inc. develops medications for oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and...
GOV. GINA M. RAIMONDO announced plans to allocate $45 million of COVID-19 relief funds to workforce development programs for those left jobless due to the pandemic. PBN FILE PHOTO/DAVE HANSEN

Raimondo announces $45M in workforce development for the unemployed

PROVIDENCE – In an effort to break down traditional barriers to hiring, Gov. Gina M. Raimondo announced on Tuesday an investment of $45 million...
AMGEN said it is pulling the higher-priced version of its cholesterol drug Repatha from the market, an effort to boost sales of the drug. The drug is manufactured n Rhode Island. / BLOOMBERG NEWS FILE PHOTO

Amgen pulls high-price version of Repatha in bid to raise sales

NEW YORK – Amgen Inc. will pull its higher-priced version of its cholesterol drug Repatha from the market, an effort to boost sales of...

Five Questions With: Carol Malysz

In her role as RI Bio’s executive director, Carol Malysz oversees the group’s coordination with health care organizations, life sciences companies, academic centers and...

Amgen will buy Celgene drug in $13.4B antitrust sale

BOSTON – Amgen Inc. will pay $13.4 billion for a blockbuster psoriasis drug from Celgene Corp., which is shedding the asset in order to...
EARLY RESULTS FROM early results from an experimental therapy developed by Amgen showed promise in colon cancer. / BLOOMBERG FILE PHOTO

Amgen stock climbs on cancer drug promise

NEW YORK – Shares of Amgen Inc. rose as much as 2.3% in pre-market trading after early results from an experimental therapy showed promise...
PBN PHOTO/MIKE SKORSKI

JENNIFER LYTLE, 36

40 Under Forty 2019 winner: JENNIFER LYTLE | 36 QUALITY ASSURANCE MANAGER, AMGEN RHODE ISLAND What is the best advice you have ever received? Success and failures...
BROADENED MISSION: Carol Malysz, executive director of Providence-based biotechnology trade association RI BIO, said the group has broadened its focus. Previously known as MedMates, this year the company changed its name and approach to promote the entire biotech industry.
 / PBN PHOTO/MICHAEL SALERNO

Ocean State starting to see growth in biotech industry

RI BIO, a Providence-based biotechnology trade association, is on a mission to put Rhode Island on the biotech industry’s map. Despite the state having...
IN COLLABORATION: Amgen Rhode Island employees discuss manufacturing data on a display screen at the West Greenwich facility. From left are manager Jennifer Gangi, senior associate Kelly Perry, associate David Folco, manager Jon Berthiaume and manager Gary Theroux.
 / PBN PHOTO/RUPERT WHITELEY

Amgen Rhode Island workers reap rewards of ‘Caring’

Best Places to Work 2019 | ENTERPRISE (500-plus employees): 1. Amgen Rhode Island WITH CAREFUL PLANNING, Amgen Rhode Island is utilizing innovation to get its...

Stay up to date with PBN's Morning Call & Daily Edition newsletters.

- Featured Event -

Latest News

SPRING SALE

CLOSE

50% off for one day only

Hurry, this offer ends in:

00
Months
00
Days
00
Hours
00
Minutes
00
Seconds

Sign-up to get the

PBN Daily Edition

A collection of all the published news of the last 24 hours, as well as selected features from PBN’s weekly print edition.

By submitting the form you agree to PBN's Privacy Policy and Terms of Use.

Exit Intent

PBN is becoming a habit.
You've exceeded our free article limit for the month. Keep reading this article with a subscription to PBN.

Keep reading this subscriber-only article

with a subscription to PBN.

ALREADY A SUBSCRIBER? LOG IN

Register to keep reading or subscribe today to get unlimited access now.

ALREADY A SUBSCRIBER? LOG IN

ANNUAL SALE

CLOSE

70% off for one day only

Hurry, this offer ends in:

00
Months
00
Days
00
Hours
00
Minutes
00
Seconds

Register to read all articles free - This week only!

CLOSE

One week only, get full access to all articles on PBN.com when you create a complimentary account.

One week only, get full access to all articles on PBN.com when you create a complimentary account.

 

Register today >>